Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia.
Chia-Hao MaHung-Yu ChanMing H HsiehChen-Chung LiuChih-Min LiuHai-Gwo HwuChing-Hua KuoWei J ChenTzung-Jeng HwangPublished in: Therapeutic advances in psychopharmacology (2022)
ClinicalTrials.gov, identifier: NCT00545467.
Keyphrases